FOXM1 and urinary bladder cancer: Moreover, we determined the protein levels of FOXM1 and FANCD2 by IHC (Immunohistochemistry) in 57 bladder cancer samples (30 nonrecurrent primary tumors and 27 recurrent primary tumors) using a tissue microarray (Figure 6C).